SG Americas Securities
WVE icon

SG Americas Securities’s Wave Life Sciences WVE Stock Holding History

SG Americas Securities’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Sell
20,923
-46,108
-69% -$601K ﹤0.01% 2769
2025
Q4 		$1.14M Buy
+67,031
New +$681K ﹤0.01% 1907
2025
Q1 		– Sell
-53,419
Closed -$661K – 3794
2024
Q4 		$661K Buy
53,419
+16,856
+46% +$225K ﹤0.01% 1113
2024
Q3 		$300K Sell
36,563
-97,264
-73% -$581K ﹤0.01% 2148
2024
Q2 		$668K Buy
+133,827
New +$763K ﹤0.01% 1524
2024
Q1 		– Sell
-34,562
Closed -$175K – 3496
2023
Q4 		$175K Buy
34,562
+8,694
+34% +$46.5K ﹤0.01% 2291
2023
Q3 		$149K Buy
+25,868
New +$118K ﹤0.01% 2504
2022
Q2 		– Sell
-486,048
Closed -$972K – 3642
2022
Q1 		$972K Sell
486,048
-330,690
-40% -$810K 0.01% 1454
2021
Q4 		$2.56M Buy
816,738
+707,924
+651% +$2.94M 0.01% 898
2021
Q3 		$533K Buy
+108,814
New +$660K ﹤0.01% 2438
2020
Q3 		– Sell
-11,137
Closed -$116K – 3534
2020
Q2 		$116K Buy
+11,137
New +$105K ﹤0.01% 3281
2019
Q2 		– Sell
-3,602
Closed -$140K – 3471
2019
Q1 		$140K Buy
+3,602
New +$146K ﹤0.01% 2832

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SG Americas Securities's WVE Position: Q1 2026 in Review

SG Americas Securities reduced its Wave Life Sciences (WVE) stake by 69% in Q1 2026, selling an estimated $601K and leaving 20,923 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

SG Americas Securities first reported a position in WVE in Q1 2019 and has held it in 12 quarters since. The position peaked at $2.56M in Q4 2021. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • SG Americas Securities held 20,923 shares of Wave Life Sciences worth $152K as of Q1 2026.
  • SG Americas Securities sold 46,108 Wave Life Sciences shares in Q1 2026, an estimated $601K.
  • Wave Life Sciences made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2769 holding.
  • SG Americas Securities first reported a position in Wave Life Sciences in Q1 2019 and has held it in 12 quarters since.
  • SG Americas Securities's Wave Life Sciences position peaked at $2.56M in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.